Summary
U.S. health officials recommend a nationwide ban on an ingredient called 7-hydroxymitragynine, found in some energy drinks and supplements, due to its opioid-like effects. This ingredient is part of kratom, a plant from Southeast Asia used for unapproved treatment of various health issues. The FDA aims to educate the public about its risks and is pushing to classify it alongside highly restricted drugs.
Key Facts
- 7-hydroxymitragynine is found in some energy drinks and supplements in the U.S.
- It is a part of kratom, a plant used for unapproved treatments like pain and anxiety relief.
- The FDA wants to ban this ingredient because it is a potent opioid.
- The FDA's focus is not on natural kratom leaf products but on the concentrated form.
- The FDA suggests putting 7-hydroxymitragynine on a list of the most restricted drugs.
- The Drug Enforcement Administration (DEA) will review the FDA's recommendation.
- Kratom products related to 7-OH have not been approved for safety by the FDA.
- There has been resistance from kratom users and distributors to regulate the plant.
